US government HIV/AIDS clinical trial sites to accelerate completion of phase III TB drug trial – EurekAlert

Moxifloxacin is a fluoroquinolone – a subset of the quinolone class of antibiotics. Developed and marketed by Bayer HealthCare AG, moxifloxacin has demonstrated efficacy for the treatment of several acute respiratory and uncomplicated skin and soft tissue infections.